[治疗晚期直肠癌的手术前化疗 (FOLFOXIRI加贝瓦西祖马布) 的结果]
Hiroto Saito1, Daisuke Yamamoto, Mari Shimada
1Dept. of Gastrointestinal Surgery, Kanazawa University Hospital.
Gan to kagaku ryoho. Cancer & chemotherapy
|February 14, 2025
概括
手术前的FOLFOXIRI加上贝瓦齐祖马布化疗为晚期直肠癌提供了高响应率,有助于实现艰难的外科手术边缘. 这种治疗对那些努力达到1毫米外围切除边缘目标的患者有好处.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠道瘤学 胃肠道瘤学
更多相关视频
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.5K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
204
